---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-034098"
form_type: "8-K"
ticker: "MTNB"
cik: "0001582554"
company_name: "Matinas BioPharma Holdings, Inc."
filed_at: "2024-08-28T23:59:59+00:00"
generated_at: "2026-05-31T07:11:15.226949+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Matinas BioPharma receives NYSE American trading halt due to low price; plans 1-for-50 reverse split

## Summary
- Trading of MTNB common stock halted by NYSE American on August 27, 2024 due to low trading price.
- Halt to remain until reverse stock split (1-for-50) is consummated; split effective 5:00 PM EST on August 30, 2024.
- Split-adjusted trading expected to begin September 3, 2024, subject to NYSE American approval.
- If post-split price does not meet Section 1003(f)(v) requirements, NYSE could suspend trading and delist shares.

## SEC filing metadata
- accession: 0001493152-24-034098
- form_type: 8-K
- ticker: MTNB
- cik: 0001582554
- company_name: Matinas BioPharma Holdings, Inc.
- filed_at: 2024-08-28T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582554/000149315224034098/0001493152-24-034098-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582554/000149315224034098/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-034098
- JSON: https://secwatch.observer/filing/0001493152-24-034098.json
- Plain text: https://secwatch.observer/filing/0001493152-24-034098.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.